The APPLE trial updated investigated the treatment strategy's impact on brain metastasis control and circulating tumour DNA progression-free survival. The study found no significant differences between upfront osimertinib or sequential treatment, but suggested a viable option for regions with first-line osimertinib access issues.
SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeCommentary/editorial·DateMay 6, 2025
A new study found that neoadjuvant dual immuno-combination therapy with relatlimab and nivolumab achieved a 93% one-year disease-free survival rate and 100% one-year overall survival rate in patients with resectable non-small cell lung cancer. The therapy also showed promising outcomes, including a pathological complete response rate o...
SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeCommentary/editorial·DateMay 6, 2025
A new study introduces the RAPID-RT study, which uses a rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. The technique aims to reduce cardiac toxicity and improve survival in lung cancer patients by minimising dose to the top of the heart, a previously identified risk area.
SourceEuropean Society for Radiotherapy and Oncology (ESTRO)·JournalRadiotherapy and Oncology·TypeRandomized controlled/clinical trial·DateMay 4, 2025
Garmin GPSMAP 67i with inReach
Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.
Researchers from the University of Southampton engineered a new type of super-strong antibody that triggers a stronger response from the immune system compared to naturally produced antibodies. The study confirms that making subtle increases in rigidity stimulates immune activity, creating a powerful immune response against disease.
SourceUniversity of Southampton·JournalNature Communications·TypeExperimental study·DateMay 1, 2025
A non-risk-based lung cancer screening approach using low-dose computed tomography (LDCT) in Chinese populations detects a significant number of early-stage lung cancers. The study found that incorporating non-high-risk individuals into screening programs can lead to a greater detection rate and improved patient outcomes.
SourceNational Center for Respiratory Medicine·JournalJAMA·TypeRandomized controlled/clinical trial·DateApr 29, 2025
A new study found that pregnancy-related glycoproteins (PSGs) are strongly associated with poorer outcomes in female lung cancer patients. The analysis suggests targeting these genes may improve survival in female patients with lung cancer, and the researchers plan to pursue further investigation into their role.
SourceMemorial Sloan Kettering Cancer Center·DateApr 29, 2025
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Researchers have developed three-dimensional spheroid cultures that better replicate cell-cell interactions and nutrient gradients, leading to a greater understanding of tumour tissue behaviour and drug responses. The study highlights the importance of mimicking tumour architecture in testing cancer therapies.
A Phase Ia/Ib trial found that zongertinib demonstrated clinical benefits for patients with advanced HER2-mutant non-small cell lung cancer, particularly those with specific HER2 mutations. The treatment showed a 71% objective response rate and manageable side effects.
SourceUniversity of Texas M. D. Anderson Cancer Center·DateApr 28, 2025
The phase Ia/Ib Beamion LUNG-1 trial found that zongertinib elicited durable responses in patients with advanced, previously treated non-small cell lung cancer (NSCLC) harboring a HER2 mutation. The disease control rate was high across cohorts, with median progression-free survival ranging from 12.4 to 6.8 months.
SourceAmerican Association for Cancer Research·JournalNew England Journal of Medicine·DateApr 28, 2025
A phase I clinical trial found that zoldonrasib elicited objective responses and disease control in patients with KRAS G12D-mutated NSCLC. The study demonstrated the efficacy and tolerability of the oral agent, which selectively targets the active conformation of KRAS.
SourceAmerican Association for Cancer Research·DateApr 27, 2025
A recent study found that cigarette smoking continues to decline across the US, mainly driven by young adults. The states with historically high smoking rates have seen the most significant declines in smoking prevalence.
SourceUniversity of California - San Diego·JournalJAMA Network Open·DateApr 25, 2025
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
Researchers found that blood cells carrying age-related mutations can infiltrate tumours, leading to worse cancer outcomes. The presence of these mutations was associated with shorter survival rates in patients with lung and other aggressive cancers.
SourceThe Francis Crick Institute·JournalNew England Journal of Medicine·TypeExperimental study·DateApr 23, 2025
Researchers developed an AI algorithm based on the medical history of over half a million patients, enabling GPs to identify increased risk of lung cancer up to 4 months before diagnosis. This method may also offer early detection for other types of cancer and improved patient outcomes.
SourceAmsterdam University Medical Center·JournalBritish Journal of General Practice·TypeData/statistical analysis·DateApr 22, 2025
Liquid biopsy analyzes circulating tumor components in body fluids to detect cancer at early stages, offering a safer and more dynamic alternative to traditional tissue biopsies. This non-invasive approach has shown promise in detecting various types of cancer, including lung, breast, colorectal, prostate, and gastric cancers.
SourceXia & He Publishing Inc.·JournalCancer Screening and Prevention·DateApr 22, 2025
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A recent preclinical study from Weill Cornell Medicine researchers suggests that three-dimensional gene hubs may promote brain cancer. The findings, published in Molecular Cell, offer a new way to think about cancer beyond gene mutations and highlight the importance of understanding DNA organization in tumor cells.
SourceWeill Cornell Medicine·JournalMolecular Cell·DateApr 22, 2025
The Lung-MAP 3.0 trial introduces a simplified genomic screening process, allowing most patients to be matched to a targeted treatment sub-study based on prior testing results. This expansion increases access to investigational treatments for patients with advanced non-small cell lung cancer.
SourceSWOG Cancer Research Network·TypeRandomized controlled/clinical trial·DateApr 16, 2025
A new study published in The Annals of Thoracic Surgery found that Medicaid expansion significantly improved access to timely treatment for patients with early-stage non-small cell lung cancer. High-volume hospitals associated with decreased postoperative complications and in-hospital mortality rates compared to low-volume hospitals.
SourceThe Society of Thoracic Surgeons·JournalThe Annals of Thoracic Surgery·TypeData/statistical analysis·DateApr 15, 2025
A new study suggests that CT scans could account for 5% of all cancer cases each year, primarily due to radiation exposure. The largest risk is among infants, followed by children and adolescents. To mitigate this risk, reducing the number of scans and doses per scan can help save lives.
SourceUniversity of California - San Francisco·JournalJAMA Internal Medicine·DateApr 14, 2025
Researchers at KAIST discovered that DDX54 is the master regulator hindering immunotherapy's effectiveness in lung cancer. Supressing DDX54 enhances immune cell infiltration into tumors and improves immunotherapy efficacy.
SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateApr 9, 2025
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
A study by the University of Barcelona reveals that dynamic BH3 profiling can predict the effectiveness of ALK inhibitors in treating non-small cell lung cancer. The technique helps select the best drug for each patient, overcoming tumour adaptations to inhibitors.
SourceUniversity of Barcelona·JournalCell Death and Disease·TypeExperimental study·DateApr 9, 2025
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed in Elsevier's Scopus database. This achievement is a testament to the high-quality research published in these journals, which provide open access content in pulmonary and critical care medicine.
SourceAmerican College of Chest Physicians·JournalCHEST Critical Care·DateApr 4, 2025
Researchers found significant cell changes in workers exposed to hexavalent chromium at levels below Sweden's current limit. The study suggests the need for stricter safety regulations and lower limits for this carcinogenic substance.
SourceLund University·JournalJournal of Hazardous Materials·TypeCase study·DateApr 2, 2025
A new study by Mass General Brigham researchers reveals that many eligible patients who receive other preventative screenings are not getting screened for lung cancer. The study found that 65% of those eligible received breast and colorectal cancer screening, a nearly 4-fold higher rate than lung cancer screening.
SourceMass General Brigham·JournalJAMA·TypeData/statistical analysis·DateApr 2, 2025
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers at MD Anderson Cancer Center made several key discoveries, including the spatial organization of cancer-associated fibroblasts across various cancers and a study on treatment resistance in SMARCA4-mutant lung cancer. These findings highlight the importance of investigating cell populations in their spatial context to better...
SourceUniversity of Texas M. D. Anderson Cancer Center·DateMar 27, 2025
Researchers discovered TBX2 drives therapy resistance by shifting signaling from the androgen receptor to the glucocorticoid receptor. The study identified a strategy to target this switch, potentially predicting patient risk and offering new treatment approaches.
SourceTexas Tech University Health Sciences Center·JournalOncogene·TypeExperimental study·DateMar 27, 2025
A new study published by the American Cancer Society estimates that tobacco control measures have averted over 3.8 million lung cancer deaths and gained 76 million years of life in the US between 1970 and 2022. The study highlights the significant impact of progress against smoking on reducing premature mortality from lung cancer.
SourceAmerican Cancer Society·JournalCA A Cancer Journal for Clinicians·DateMar 25, 2025
Dr. John Turchi, a leading lung cancer researcher, has been appointed as the inaugural executive director of the Tom and Julie Wood Center for Lung Cancer Research at Indiana University. The center aims to advance lung cancer research and improve patient outcomes through innovative therapies and personalized care.
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
A study published in the British Journal of General Practice found a significant link between chest x-ray referrals and earlier lung cancer diagnosis and better survival rates. Patients attending practices with high chest x-ray usage were more likely to be diagnosed at an earlier stage, leading to improved survival rates.
SourceUniversity of Sheffield·JournalBritish Journal of General Practice·TypeObservational study·DateMar 24, 2025
A new editorial highlights a growing concern in cancer care: radiotherapy may leave behind residual disease that can lead to worse long-term outcomes. Studies have shown that patients with residual disease are more likely to experience cancer recurrence and shorter survival, emphasizing the need for regular biopsy-based tests.
SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateMar 21, 2025
New leukemia treatment combination shows promise for patients with follicular lymphoma. Immunotherapy research also explores ways to suppress protein ZNF638 to boost effectiveness of immune checkpoint inhibitors. Innovative funding efforts support Sylvester's cancer research initiatives.
SourceUniversity of Miami Miller School of Medicine·DateMar 21, 2025
The updated guidelines substantially increased lung cancer screenings overall, but disparities persist among people with limited access to healthcare. Barriers include cost, knowledge, and lack of primary care providers, with mobile units and patient navigators offering potential solutions.
SourceUniversity of Miami Miller School of Medicine·JournalJAMA Oncology·DateMar 20, 2025
The European Lung Cancer Congress 2025 will take place in Paris from March 26-29, featuring renowned experts discussing the latest research on lung cancer prevention, diagnosis, and treatment. The congress will also include award lectures and live streaming of the event.
SourceEuropean Society for Medical Oncology·DateMar 20, 2025
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
A multicenter cohort study found that higher adherence to annual lung cancer screening was associated with increased overall and early-stage lung cancer detection rates. However, adherence decreased over time, suggesting it is a critical quality metric for lung cancer screening.
SourceJAMA Network·JournalJAMA Network Open·DateMar 18, 2025
This cohort study found that geographic access to cancer care is associated with guideline-recommended treatment for early-stage non–small cell lung cancer. Socially marginalized patients benefited from improved treatment outcomes and prognosis when accessing care in their local area.
SourceJAMA Network·JournalJAMA Network Open·DateMar 18, 2025
A post-treatment blood test measures cancer-derived molecules in patients with lung cancer years after treatment. This tool can inform clinical intervention, including restarting or intensifying treatment for high-risk patients.
SourceYale University·JournalNature Medicine·DateMar 17, 2025
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
Researchers found that a Western-style diet high in glycogen can fuel lung cancer tumors, leading to faster growth and worse outcomes. A nutrient-rich diet, active lifestyle, and reduced alcohol intake are recommended for lung cancer prevention.
SourceUniversity of Florida·JournalNature Metabolism·TypeExperimental study·DateMar 13, 2025
Breast cancer death rates are predicted to increase in EU patients aged 80 years and older, while falling in all other age groups. This is attributed to a lack of regular screening and access to modern treatments.
SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeObservational study·DateMar 11, 2025
Scientists at VCU Massey Comprehensive Cancer Center have discovered a powerful combination therapy that leverages sotorasib and FGTI-2734 to tackle drug resistance in lung cancer. The treatment targets the KRAS G12C mutation, which is responsible for about 14% of non-small cell lung cancers.
SourceVirginia Commonwealth University·JournalJournal of Thoracic Oncology·DateMar 10, 2025
A study of nearly 2,500 postmenopausal women found that taking more daily steps and engaging in moderate-to-vigorous physical activity were associated with a significantly reduced risk of death from cardiovascular disease. Even walking fewer than 5,000 steps per day showed a risk reduction.
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Short-course corticosteroid treatment was associated with lower surgical site complications and in-hospital mortality in patients with postoperative acute lung injury following lung resection surgery. The optimal duration of corticosteroid treatment remains uncertain, highlighting the need to weigh benefits against adverse effects.
SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateFeb 25, 2025
Researchers at Tufts University have developed a cancer vaccine that amplifies the visibility of tumor antigens to the immune system, leading to potent responses and lasting immunological memory. The vaccine works against multiple solid tumors in animal models, including melanoma, triple-negative breast cancer, and ovarian cancer.
SourceTufts University·JournalNature Biomedical Engineering·TypeExperimental study·DateFeb 24, 2025
The hybrid operating room enables the entire procedure to be performed in a single step, allowing for more precise positioning of the thoracic endoprosthesis. This approach requires collaboration between thoracic surgeons and vascular surgeons.
SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeNews article·DateFeb 20, 2025
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
A new laser-based device can analyze gas samples with high precision, detecting molecules at minute concentrations. The technology has potential applications in medical diagnostics, tracking greenhouse gas emissions, and more.
SourceUniversity of Colorado at Boulder·JournalNature·DateFeb 19, 2025
Cancer cells work together to source nutrients from their environment, a cooperative process that can be targeted for treating cancer. Researchers identified key enzymes and mechanisms behind this cooperation, including the enzyme CNDP2, which can be inhibited by the drug bestatin.
The Lung Cancer Research Foundation and Israel Cancer Research Fund are partnering to test an innovative new treatment for lung cancer. The project aims to explore the effects of a drug that targets IGF2BP1, a protein involved in cancer cell growth.
SourceThe Hebrew University of Jerusalem·TypeExperimental study·DateFeb 18, 2025
A study found that 77.9% of lung cancer patients had detectable atherosclerosis on CT scans, with smoking being the most prominent cardiac risk factor. The results suggest using concurrent coronary calcium scoring to aid in identification and earlier intervention for these patients.
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
The study reveals that certain DNA regions are more prone to damage but also better repaired by cells. Transcription factors can either help or harm DNA, highlighting the importance of efficient repair in determining mutation formation.
SourceThe Hebrew University of Jerusalem·JournalNucleic Acids Research·TypeExperimental study·DateFeb 12, 2025
A study found that MAGE-4 drives the accumulation of plasma immune cells suppressing antitumor immunity in mouse and human non-small cell lung cancer models. The protein promotes tumor progression by losing a tumor suppressor gene, PTEN, accelerating development into metastasis.
SourceBaylor College of Medicine·JournalScience Advances·TypeExperimental study·DateFeb 12, 2025
Researchers at University of California, Merced are using wastewater-based epidemiology to track nicotine use in San Joaquin Valley communities. The project aims to determine trends and levels of nicotine use through chemicals in wastewater, providing valuable insights for public health agencies and tobacco-control researchers.
Scientists have pinpointed a weakness in lung cancer's defenses by uncovering an enzyme that boosts cancer cell metabolism to fuel growth. Researchers identified GUK1 as a metabolic enzyme that plays a crucial role in ALK-positive cancers, suggesting it may be a target for new therapies.
The Micro Immune Response On chip (MIRO) replicates tumours and their environment, allowing researchers to study the efficacy of immunotherapy treatments. This technology has been tested with breast cancer samples and shows promise in understanding how the immune system interacts with tumours.
SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalNature Communications·TypeExperimental study·DateFeb 6, 2025
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
A new genetic mutation, RUFY1-RET fusion, was discovered in a patient with stage IV CD-74-ROS1 fusion NSCLC who developed resistance to lorlatinib. The finding highlights the importance of ongoing genetic testing to guide therapy decisions.
SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateFeb 6, 2025
A new low-cost, fast response sensor has been developed to detect lung cancer biomarkers, enabling early diagnosis and improved patient outcomes. The technology can identify patients at higher risk of lung cancer and tailor treatments for those already diagnosed.
SourceCranfield University·JournalBiosensors·DateFeb 6, 2025
Researchers developed a computer model called MANAscore to identify tumor-fighting immune cells in lung cancer patients treated with immune checkpoint inhibitors. The three-gene model helped find differences associated with patient response to immunotherapy, including the presence of stem-like memory T cells.
SourceJohns Hopkins Medicine·JournalNature Communications·DateFeb 3, 2025
Researchers at H. Lee Moffitt Cancer Center discovered a biomarker that can predict which lung cancer patients with KRASG12C mutation are most likely to benefit from targeted treatments. The study found that tumors with higher levels of RAS-RAF protein interaction respond better to KRASG12C inhibitors.
SourceH. Lee Moffitt Cancer Center & Research Institute·JournalClinical Cancer Research·TypeObservational study·DateJan 31, 2025
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
The addition of da Vinci 5 robotic surgical systems at Huntsman Cancer Institute offers enhanced precision and control during minimally invasive surgeries. The system's advanced technology enables complex procedures to be performed through small incisions, reducing hospital stays and accelerating recovery times for patients.
The study analyzed 63 tumor samples from 10 common malignancies, revealing how malignant cells specialize in growing tumors and non-cancer cells contribute to the immune system's suppression. The findings suggest a hierarchical structure of tumors with specific hallmark expression patterns.
SourceJosep Carreras Leukaemia Research Institute·JournalCell Reports·TypeExperimental study·DateJan 29, 2025
A pooled data analysis found that cancer chemotherapy is linked to persistent severe peripheral nerve pain for around 4 in every 10 patients, with platinum-based drugs and taxanes associated with the highest rates of painful neuropathy. The study analyzed data from 77 eligible studies involving 10,962 participants from 28 countries.
SourceBMJ Group·JournalRegional Anesthesia & Pain Medicine·TypeObservational study·DateJan 28, 2025
Research presented at the 2025 STS Annual Meeting reveals that anatomic lung resections such as lobectomy and segmentectomy are associated with improved long-term survival compared to wedge resection for stage 1A NSCLC. Lobectomy offered the highest survival rates, with a 71.9% 5-year OS and 44.8% 10-year OS.
The Chris Chang Lab develops a copper-detection tool to uncover how copper regulates cell growth in lung cancer. The probe identifies cells with elevated copper levels and reveals a connection between copper and the antioxidant response mediated by NRF2.
SourcePrinceton University·TypeExperimental study·DateJan 22, 2025
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.